News
iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201
iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has selected IBIO-201, its LicKMâ„¢-ubunit vaccine, as its leading candidate for the...
News
ECCRT and IDDI establish partnership for continuous development of...
European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning by IDDI, a BIOSTATISTICAL AND ECLINICAL SERVICES...
News
Catalent Invests $130 Million to Add Additional Manufacturing Capacity...
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced...
News
Sheba Medical Center Treats First Patient with CAR-T Cell...
“Treatment of the first patient is a significant milestone for Lonza and demonstrates the Cocoon’s capability to manufacture patient-scale cellular immunotherapies in a cGMP setting...
News
Oxford University vaccine trial paused after participant falls ill
Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected adverse...
IT & Data Management
Chugai and NTT DATA Complete Demonstration of AI-based Clinical...
Chugai Pharmaceutical Co., Ltd. and NTT DATA Corporation have conducted a demonstration test of a solution for improving the efficiency of clinical trial-related document preparation...
News
Avacta to Launch SARS-CoV-2 ELISA Laboratory Test
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.